Sign in
4

Changes in Ownership

NewAmsterdam Pharma Co N.V. Filed Acc 0000950170-25-010575

Chief Operating Officer sold 129,559 shares

  • Chief Operating Officer acquired 129,559 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Kling Douglas F · Chief Operating Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Owned after D/I
2025-01-27 Exercise or conversion : show line 1 in the form 10b5-1 +104,174 148,174 D
2025-01-27 Sale : show line 2 in the form 10b5-1 −80,359 67,815 D
2025-01-27 Sale : show line 3 in the form 10b5-1 −23,815 44,000 D
2025-01-28 Exercise or conversion : show line 4 in the form 10b5-1 +25,385 69,385 D
2025-01-28 Sale : show line 5 in the form 10b5-1 −20,237 49,148 D
2025-01-28 Sale : show line 6 in the form 10b5-1 −5,148 44,000 D
Open-market sales · 129,559 sh

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-01-27 Exercise or conversion : show line 7 in the form 10b5-1 Option (right to buy) −104,174 321,971 D
2025-01-28 Exercise or conversion : show line 8 in the form 10b5-1 Option (right to buy) −25,385 296,586 D
Loading xslF345X05/ownership.xml…